Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes

Invariant natural killer T lymphocytes （iNKT） are hybrids between innate and adaptive immune ceils and exert their effector functions by binding to glycolipids. Endogenous ligands can also stimulate iNKTs to perform their functions） However,